Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Longitudinal Retinal Perfusion Status in Eyes with Diabetic Macular Edema Receiving Intravitreal Aflibercept or Laser in VISTA Study.

Wykoff CC, Shah C, Dhoot D, Coleman HR, Thompson D, Du W, Baker K, Vitti R, Berliner AJ, Metzig C, Saroj N.

Ophthalmology. 2019 Aug;126(8):1171-1180. doi: 10.1016/j.ophtha.2019.03.040. Epub 2019 Apr 1.

PMID:
30946887
2.

Evaluation of the age-related eye disease study clinical lens grading system AREDS report No. 31.

Chew EY, Kim J, Sperduto RD, Datiles MB 3rd, Coleman HR, Thompson DJ, Milton RC, Clayton JA, Hubbard LD, Danis RP, Ferris FL 3rd.

Ophthalmology. 2010 Nov;117(11):2112-9.e3. doi: 10.1016/j.ophtha.2010.02.033. Epub 2010 Jun 18.

3.

Preliminary assessment of celecoxib and microdiode pulse laser treatment of diabetic macular edema.

Chew EY, Kim J, Coleman HR, Aiello LP, Fish G, Ip M, Haller JA, Figueroa M, Martin D, Callanan D, Avery R, Hammel K, Thompson DJ, Ferris FL 3rd.

Retina. 2010 Mar;30(3):459-67. doi: 10.1097/IAE.0b013e3181bcf1a0.

4.

Age-related macular degeneration.

Coleman HR, Chan CC, Ferris FL 3rd, Chew EY.

Lancet. 2008 Nov 22;372(9652):1835-45. doi: 10.1016/S0140-6736(08)61759-6.

5.

Intravitreal ranibizumab therapy for retinal capillary hemangioblastoma related to von Hippel-Lindau disease.

Wong WT, Liang KJ, Hammel K, Coleman HR, Chew EY.

Ophthalmology. 2008 Nov;115(11):1957-64. doi: 10.1016/j.ophtha.2008.04.033. Epub 2008 Sep 11.

6.

Retinal vascular proliferation as an ocular manifestation of von Hippel-Lindau disease.

Wong WT, Yeh S, Chan CC, Kalina RE, Kinyoun JL, Folk JC, Coleman HR, Chew EY.

Arch Ophthalmol. 2008 May;126(5):637-43. doi: 10.1001/archopht.126.5.637.

7.

Oral supplementation of lutein/zeaxanthin and omega-3 long chain polyunsaturated fatty acids in persons aged 60 years or older, with or without AMD.

Huang LL, Coleman HR, Kim J, de Monasterio F, Wong WT, Schleicher RL, Ferris FL 3rd, Chew EY.

Invest Ophthalmol Vis Sci. 2008 Sep;49(9):3864-9. doi: 10.1167/iovs.07-1420. Epub 2008 Apr 30.

PMID:
18450596
8.

Clinical characterization of retinal capillary hemangioblastomas in a large population of patients with von Hippel-Lindau disease.

Wong WT, Agrón E, Coleman HR, Tran T, Reed GF, Csaky K, Chew EY.

Ophthalmology. 2008 Jan;115(1):181-8. Epub 2007 Jun 1.

9.

Genotype-phenotype correlation in von Hippel-Lindau disease with retinal angiomatosis.

Wong WT, Agrón E, Coleman HR, Reed GF, Csaky K, Peterson J, Glenn G, Linehan WM, Albert P, Chew EY.

Arch Ophthalmol. 2007 Feb;125(2):239-45.

10.

A case study of an older adult with severe anemia refusing blood transfusion.

Thomas CM, Coleman HR, Morritt Taub LF.

J Am Acad Nurse Pract. 2007 Jan;19(1):43-8. Review.

PMID:
17214867
11.

Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants.

Sieving PA, Caruso RC, Tao W, Coleman HR, Thompson DJ, Fullmer KR, Bush RA.

Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3896-901. Epub 2006 Feb 27.

Supplemental Content

Loading ...
Support Center